VYMADA 50MG TABLET
14 Tablet(s) in StripMRP ₹732.50
₹534.73
27% OFF
Made by
NOVARTIS HEALTHCARE PVT LTD
Dosage
TABLET
Expiry
Product Summary
| Salt Content | Valsartan(26.0 Mg)+Sacubitril(24.0 Mg) |
| Uses | Heart failure |
| Therapy | Drugs for congestive heart failure |
| Side effects | Dizziness, light-headedness, nausea, headache, fainting |
Assurance
available
Regulated
Medical Description
Vymada 50mg is a medication used to treat heart failure. It's a combination of two drugs: sacubitril and valsartan. Heart failure occurs when the heart weakens and struggles to pump enough blood throughout the body. This can lead to various symptoms, including shortness of breath, fatigue, tiredness, and swelling around the ankles.
Sacubitril helps by relaxing blood vessels, which lowers blood pressure and increases the removal of excess fluid from the body. Valsartan also relaxes blood vessels, making it easier for the heart to pump blood effectively.
It's crucial to take Vymada 50mg precisely as prescribed by your doctor. Do not skip or miss doses, as this can worsen your heart condition. Suddenly stopping Vymada can also have serious consequences.
Common side effects of Vymada 50mg may include dizziness, lightheadedness, nausea, headache, and fainting.
Uses
Contraindications
- If you are allergic to sacubitril, valsartan or any other ingredients of Vyamda 50.
- If you have diabetes or kidney disease and taking aliskiren-containing blood pressure-lowering medicine.
- If you have severe liver disease.
- If you are pregnant and pregnancy is of more than 3 months.
- If you are taking any medicines from the angiotensin-converting enzyme (ACE) inhibitor group of medicine used for the treatment of high blood pressure or heart failure, you should wait for at least 36 hours after taking the last dose, before taking Vymada 50mg tablet.
- If you or any member of your family has a history of swelling of lips, face, tongue, or throat after taking any medicine from the ACE inhibitor group of medicine or angiotensin II receptor blocker group of medicine.
Side effects
- Dizziness
- Light-headedness
- Nausea
- Headache
- Fainting
- Loose motions
- Cough
- Tiredness or weakness
- Pain in stomach
- Spinning sensation
Precautions and Warnings
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You are taking medicines such as aliskiren and any medicine from the angiotensin II receptor blocker group of medicine.
- You have swelling of lips, face, tongue, and throat after taking this medicine.
- You have low blood pressure or taking any other medicine to lower blood pressure.
- You have vomiting, loose motions or has dehydration, and your age is more than 65 years.
- You have kidney disease and low blood pressure.
- You have severe kidney disease or liver disease.
- Your kidney artery has been narrowed.
Directions for Use
- Take this medicine with or without food as prescribed by your doctor.
- Do not stop taking Vymada 50mg tablet on your own.
- Take it regularly at the same time for optimal results.
Storage and disposal
- Store Vymada 50mg tablet at room temperature and away from light.
- Keep away from children and pets. Store this medicine in the original package to protect it from moisture.
Quick Tips
- Vymada 50 mg table is used in the treatment of heart failure in patients having a type of long-term heart failure.
- Take Vymada 50 as prescribed by your doctor for the prescribed duration. Do not skip or miss the dose of Vymada 50mg.
- If you stop taking Vymada suddenly, it may worsen the disease condition.
- Inform your doctor if you have a history of liver or kidney diseases.
- Dizziness, light-headedness, nausea, headache and fainting are a few common side effects of Vymada. These side effects are usually mild and resolve with time.
Dosage
Overdose
Missed a Dose
Mode of Action
How Does It Work?
- Sacubitril lowers blood pressure by causing blood vessel relaxation, excretion of sodium through urine and increasing urination.
- Valsartan works by relaxation of blood vessels so that the heart pumps blood more easily through blood vessels to the body.
Interactions
Interactions with other medicines
- Vymada 50mg can interact with several other medications, potentially leading to serious side effects.
- ACE Inhibitors: Combining Vymada with ACE inhibitors (like enalapril or lisinopril) significantly increases the risk of angioedema, a severe allergic reaction causing facial swelling.
- Aliskiren: Concomitant use with aliskiren (another blood pressure medication) can dangerously lower blood pressure, increase potassium levels, and impair kidney function.
- Sildenafil (Viagra): Combining Vymada with sildenafil can further decrease blood pressure, potentially causing dizziness or fainting.
- Potassium-Sparing Diuretics: Medications like triamterene, amiloride, spironolactone, and eplerenone, along with potassium supplements or salt substitutes, can increase potassium levels when taken with Vymada.
- NSAIDs (Non-Steroidal Anti-Inflammatory Drugs): In elderly individuals with dehydration or kidney disease, combining Vymada with NSAIDs (like ibuprofen or naproxen) can worsen kidney function.
Interactions with food items
Frequently Asked Questions (FAQs)
Articles
View AllChronic Condition Articles
View AllDid you find this helpful?
Explore More at Pharmeasy
Manufacturer Details
Brand:VYMADA
Manufacturer Name:NOVARTIS HEALTHCARE PVT LTD
Address:Novartis Farma Spa, Via Provinciale Schito 13180058 , Torre Annunziata (Na), Italy
Country of Origin:Italy
Vendor Details
Fulfillment Information: Vymada 50mg Strip Of 14 Tablets will be delivered by a licensed retail pharmacy nearest to your location. Order acceptance and fulfillment are dependent upon the verification of your doctor's valid prescription (where applicable) and the current stock of this medicine.
References:
- Entresto 97 mg/103 mg film-coated tablets- Summary of Product Characteristics (SmPC) - (emc) [Internet]. Medicines.org.uk. 2022 [cited 16 April 2022]
- Entresto 97 mg/103 mg film-coated tablets [Internet]. Medicines.org.uk. 2022 [cited 16 April 2022]
- DrugBank. Sacubitril [Internet]. [cited 2025 Jan 8].
- National Center for Biotechnology Information (2025). PubChem Compound Summary for CID 9811834, Sacubitril. Retrieved January 8, 2025
- Nicolas D, Kerndt CC, Patel P, et al. Sacubitril-Valsartan. [Updated 2024 Feb 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. [Cited 2025 Jan 8].
- ScienceDirect. Sacubitril [Internet]. [cited 2025 Jan 8].
In Case of Any Issues Contact Us
Email Id:care@pharmeasy.in
Phone Number:7666100300
Address:D-37/1, Opp. Sandoz, TTC Industrial Area, MIDC Industrial Area, Turbhe, Navi Mumbai, Maharashtra 400703
Disclaimer
The information provided herein is supplied to the best of our abilities to make it accurate and reliable as it is published after a review by a team of professionals. This information is solely intended to provide a general overview on the product and must be used for informational purposes only. You should not use the information provided herein to diagnose, prevent, or cure a health problem. Nothing contained on this page is intended to create a doctor-patient relationship, replace or be a substitute for a registered medical practitioner's medical treatment/advice or consultation. The absence of any information or warning to any medicine shall not be considered and assumed as an implied assurance. We highly recommend that you consult your registered medical practitioner for all queries or doubts related to your medical condition. You hereby agree that you shall not make any health or medical-related decision based in whole or in part on anything contained in the Site. Please click here for detailed T&C.
























